The Republican Research and Practical Center for Epidemiology and Microbiology
9
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Algorithm for Predicting the Unfavorable Course of Sepsis in Children
Role: lead
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
Role: lead
Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
Role: lead
Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
Role: collaborator
Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer
Role: lead
Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells
Role: lead
Study of the Laboratory-based Evaluation of the Degrees of Activity of Osteoarthritis
Role: lead
Differential Diagnostics of Etiology of Acute Infections
Role: lead
Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Role: lead
All 9 trials loaded